HomeNewsBusinessStocksBuy Glenmark Pharma; target of Rs 400: Firstcall Research

Buy Glenmark Pharma; target of Rs 400: Firstcall Research

Firstcall Research is bullish on Glenmark Pharmaceuticals and has recommended buy rating on the stock with a target of Rs 400 in its January 7, 2011 research report.

January 10, 2011 / 12:49 IST
Story continues below Advertisement

Firstcall Research is bullish on Glenmark Pharmaceuticals and has recommended buy rating on the stock with a target of Rs 400 in its January 7, 2011 research report.

first published: Jan 10, 2011 12:43 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!